Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01860950 · ClinicalTrials.gov registry record · NA
Effects of Transcranial Direct Current Stimulation on Pain Perception
A NA study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 79
- Enrollment target
NCT01860950 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 79 participants.
The verdict
NCT01860950, a NA study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 79 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a new medical technology can temporarily alter pain perception. The new technology is called Transcranial direct current stimulation (tDCS).
Interventions
- DEVICE sham tDCS
- DEVICE anodal tDCS
- DEVICE cathodal tDCS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2012-10 |
| Est. Completion | 2016-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01860950
The ClinicalTrials.gov registry entry for NCT01860950 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which sham tDCS is the first listed.
NCT01860950 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01860950 about?
NCT01860950 is a clinical study titled "Effects of Transcranial Direct Current Stimulation on Pain Perception". The purpose of this study is to determine whether a new medical technology can temporarily alter pain perception. The new technology is called Transcranial direct current stimulation (tDCS).
What is the current status of trial NCT01860950?
This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2012-10. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01860950?
The interventions under investigation include: sham tDCS (DEVICE), anodal tDCS (DEVICE), cathodal tDCS (DEVICE).
Who is sponsoring clinical trial NCT01860950?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.